Evolution and pathogenicity of NDM-1 positive Escherichia coli [ 2012 - 2015 ]

Research Grant

Researchers: Prof Mark Schembri (Principal investigator) ,  Prof Timothy Walsh (Principal investigator) ,  A/Pr Scott Beatson

Brief description Antibiotic resistance (AR), as highlighted by the WHO, is the most pressing medical need of the 21C – some infections are now untreatable. Our research will focus on the new "superbug" NDM-1 positive E. coli. We will correlate AR and pathogenicity and explore the evolution of these "superbugs" using state-of-the-art sequencing. This research will benefit Australian medicine by predicting timelines of AR epidemics and by conducting the first analyses on the virulence potential of these strains.

Funding Amount $AUD 643,275.09

Funding Scheme Project Grants

Notes Standard Project Grant